SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/29/16 Orthofix Medical Inc. 10-K 12/31/15 100:15M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.33M 2: EX-21.1 Subsidiaries List HTML 33K 3: EX-23.1 Consent of Experts or Counsel HTML 34K 4: EX-31.1 Certification -- §302 - SOA'02 HTML 39K 5: EX-31.2 Certification -- §302 - SOA'02 HTML 39K 6: EX-32.1 Certification -- §906 - SOA'02 HTML 35K 13: R1 Document and Entity Information HTML 60K 14: R2 Consolidated Balance Sheets HTML 102K 15: R3 Consolidated Balance Sheets (Parenthetical) HTML 43K 16: R4 Consolidated Statements of Operations and HTML 131K Comprehensive Loss 17: R5 Consolidated Statements of Changes in HTML 73K Shareholders' Equity 18: R6 Consolidated Statements of Changes in HTML 36K Shareholders' Equity (Parenthetical) 19: R7 Consolidated Statements of Cash Flows HTML 135K 20: R8 Description of business HTML 33K 21: R9 Summary of significant accounting policies HTML 171K 22: R10 Inventories HTML 61K 23: R11 Property, plant and equipment HTML 64K 24: R12 Patents and other intangible assets HTML 90K 25: R13 Goodwill HTML 53K 26: R14 Other current liabilities HTML 54K 27: R15 Long-term debt HTML 45K 28: R16 Shareholder's equity HTML 41K 29: R17 Derivative instruments HTML 78K 30: R18 Fair value measurements HTML 194K 31: R19 Commitments HTML 52K 32: R20 Business segment information HTML 262K 33: R21 Income taxes HTML 304K 34: R22 Contingencies HTML 74K 35: R23 Pensions and deferred compensation HTML 40K 36: R24 Share-based compensation plans HTML 311K 37: R25 Earnings per share HTML 37K 38: R26 Quarterly financial data (Unaudited) HTML 286K 39: R27 Summary of significant accounting policies HTML 231K (Policies) 40: R28 Summary of significant accounting policies HTML 87K (Tables) 41: R29 Inventories (Tables) HTML 60K 42: R30 Property, plant and equipment (Tables) HTML 59K 43: R31 Patents and other intangible assets (Tables) HTML 90K 44: R32 Goodwill (Tables) HTML 54K 45: R33 Other current liabilities (Tables) HTML 53K 46: R34 Derivative instruments (Tables) HTML 70K 47: R35 Fair value measurements (Tables) HTML 182K 48: R36 Commitments (Tables) HTML 47K 49: R37 Business segment information (Tables) HTML 257K 50: R38 Income taxes (Tables) HTML 306K 51: R39 Share-based compensation plans (Tables) HTML 306K 52: R40 Quarterly financial data (Unaudited) (Tables) HTML 284K 53: R41 Description of Business - Additional Information HTML 32K (Detail) 54: R42 Summary of Significant Accounting Policies - HTML 103K Additional Information (Detail) 55: R43 Summary of Significant Accounting Policies - HTML 45K Schedule of Useful Lives (Detail) 56: R44 Summary of Significant Accounting Policies - HTML 56K Schedule of Components of Changes in Accumulated Other Comprehensive Income (Loss) (Detail) 57: R45 Summary of Significant Accounting Policies - HTML 49K Schedule of Components of Changes in Accumulated Other Comprehensive Income (Loss) (Parenthetical) (Detail) 58: R46 Inventories - Schedule of Inventories (Detail) HTML 46K 59: R47 Property, Plant and Equipment - Schedule of HTML 45K Property,Plant and Equipment (Detail) 60: R48 Property, Plant and Equipment - Additional HTML 38K Information (Detail) 61: R49 Patents and Other Intangible Assets - Schedule of HTML 44K Patents and Other Intangibles Assets (Detail) 62: R50 Patents and Other Intangible Assets - Additional HTML 33K Information (Detail) 63: R51 Patents and Other Intangible Assets - Schedule of HTML 46K Future Amortization Expense (Detail) 64: R52 Goodwill - Schedule of Net Carrying Amount of HTML 37K Goodwill (Detail) 65: R53 Other Current Liabilities - Summary of Other HTML 42K Current Liabilities (Detail) 66: R54 Long-Term Debt - Additional Information (Detail) HTML 106K 67: R55 Stockholders' equity - Additional Information HTML 40K (Detail) 68: R56 Derivative Instruments - Schedule of Fair Values HTML 40K of Derivative Instruments (Detail) 69: R57 Derivative Instruments - Schedule of Gain (Loss) HTML 37K Recognized in Other Comprehensive Income (Loss) (Detail) 70: R58 Derivative Instruments - Additional Information HTML 55K (Detail) 71: R59 Fair Value Measurements - Schedule of Financial HTML 65K Assets and Liabilities Recorded at Fair Value on Recurring Basis (Detail) 72: R60 Fair Value Measurements - Additional Information HTML 55K (Detail) 73: R61 Fair Value Measurements - Schedule of HTML 43K Reconciliation of Debt Securities (Detail) 74: R62 Commitments - Additional Information (Detail) HTML 36K 75: R63 Commitments - Schedule of Future Minimum Lease HTML 44K Payments Under Operating Leases (Detail) 76: R64 Business Segment Information - Additional HTML 31K Information (Detail) 77: R65 Business Segment Information - Schedule of Net HTML 52K Sales by SBU Reporting Segment (Detail) 78: R66 Business Segment Information - Summary of Net HTML 77K Margin, Defined as Gross Profit Less Sales and Marketing Expenses from Continuing Operations by SBU Reporting Segment (Detail) 79: R67 Business Segment Information - Schedule of HTML 45K Depreciation and Amortization by SBU Reporting Segment (Detail) 80: R68 Business Segment Information - Summary of Net HTML 53K Sales by Geographic Destination (Detail) 81: R69 Business Segment Information - Summary of HTML 44K Property, Plant and Equipment of Reporting Segments by Geographic Area (Detail) 82: R70 Income Taxes - Schedule of Income (Loss) from HTML 38K Continuing Operations Before Provision for Income Taxes (Detail) 83: R71 Income Taxes - Schedule of Provision for (Benefit HTML 53K from) Income Taxes on Continuing Operations (Detail) 84: R72 Income Taxes - Schedule of Tax Effects of HTML 68K Significant Temporary Differences Comprising Deferred Tax Assets and Liabilities (Detail) 85: R73 Income Taxes - Additional Information (Detail) HTML 45K 86: R74 Income Taxes - Schedule of Effective Income Tax HTML 91K Rate Reconciliation for Continuing Operations (Detail) 87: R75 Income Taxes - Schedule of Gross Unrecognized Tax HTML 39K Benefits (Excluding Interest and Penalties) (Detail) 88: R76 Contingencies - Additional Information (Detail) HTML 67K 89: R77 Pensions and Deferred Compensation - Additional HTML 68K Information (Detail) 90: R78 Share-based Compensation plans - Additional HTML 114K Information (Detail) 91: R79 Share-based Compensation Plans - Schedule of HTML 51K Share-Based Compensation by Line Item in Consolidated Statements of Operations (Detail) 92: R80 Share-based Compensation Plans - Schedule of HTML 46K Share-based Payment Award, Valuation Assumptions (Detail) 93: R81 Share-based Compensation Plans - Schedule of Stock HTML 68K Option Activity (Detail) 94: R82 Share-based Compensation Plans - Schedule of Stock HTML 99K Options Outstanding and Exercisable by Exercise Price Range (Detail) 95: R83 Share-based Compensation Plans - Schedule of HTML 58K Changes in Restricted Stock (Detail) 96: R84 Earnings Per Share - Additional Information HTML 48K (Detail) 97: R85 Quarterly Financial Data - Condensed Consolidated HTML 74K Statement of Operations (Detail) 99: XML IDEA XML File -- Filing Summary XML 188K 98: EXCEL IDEA Workbook of Financial Reports XLSX 121K 7: EX-101.INS XBRL Instance -- ofix-20151231 XML 4.57M 9: EX-101.CAL XBRL Calculations -- ofix-20151231_cal XML 239K 10: EX-101.DEF XBRL Definitions -- ofix-20151231_def XML 665K 11: EX-101.LAB XBRL Labels -- ofix-20151231_lab XML 1.58M 12: EX-101.PRE XBRL Presentations -- ofix-20151231_pre XML 1.20M 8: EX-101.SCH XBRL Schema -- ofix-20151231 XSD 238K 100: ZIP XBRL Zipped Folder -- 0001564590-16-013722-xbrl Zip 245K
CERTIFICATION
I, Doug Rice, certify that:
1. |
I have reviewed this annual report on Form 10-K of Orthofix International N.V.; |
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. |
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
a. |
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
b. |
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
c. |
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
d. |
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has material affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. |
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
a. |
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
b. |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
|
|
|
|
|
|
|
Dated: February 29, 2016 |
|
|
|
By: |
|
/s/ DOUG RICE |
|
|
|
|
|
|
Name: Doug Rice |
|
|
|
|
|
|
Title: Chief Financial Officer |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 2/29/16 | 8-K | ||
For Period end: | 12/31/15 | SD | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/09/16 SEC UPLOAD¶ 9/24/17 1:37K Orthofix Medical Inc. 7/13/16 SEC UPLOAD¶ 9/24/17 1:162K Orthofix Medical Inc. |